$POCI
PRECISION OPTICS CORPORATION, INC. Stock $poci

$poci Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000168316823006801 Filed on September 28, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$4.321M	$5.020M	$21.04M
YoY Change	-15.02%	4.72%	34.23%
Cost Of Revenue	$2.858M	$3.270M	$13.31M
YoY Change	-14.97%	-2.45%	23.82%
Gross Profit	$1.464M	$1.760M	$7.734M
YoY Change	-15.14%	22.11%	56.94%
Gross Profit Margin	33.87%	35.06%	36.75%
Selling, General & Admin	$1.656M	$2.040M	$7.380M
YoY Change	10.72%	24.49%	31.47%
% of Gross Profit	113.15%	115.91%	95.43%
Research & Development	$212.8K	$330.0K	$992.4K
YoY Change	-13.33%	41.49%	48.9%
% of Gross Profit	14.54%	18.75%	12.83%
Depreciation & Amortization	$51.56K	$50.00K	$210.7K
YoY Change	-1.62%	-4.49%	10.78%
% of Gross Profit	3.52%	2.84%	2.72%
Operating Expenses	$1.869M	$2.370M	$8.373M
YoY Change	7.33%	26.61%	29.97%
Operating Profit	-$405.3K	-$610.0K	-$638.5K
YoY Change	2343.14%	41.69%	-57.82%
Interest Expense	$59.12K	-$50.00K	$218.9K
YoY Change	3.86%	-2.67%	40.65%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$464.4K	-$90.00K	-$142.7K
YoY Change	563.46%	-133.3%	-84.62%
Income Tax		$0.00	$1.936K
% Of Pretax Income
Net Earnings	-$464.4K	-$100.0K	-$144.6K
YoY Change	531.76%	-137.13%	-84.42%
Net Earnings / Revenue	-10.75%	-1.99%	-0.69%
Basic Earnings Per Share	-$0.08		-$0.03
Diluted Earnings Per Share	-$0.08	-$0.02	-$0.03
COMMON SHARES
Basic Shares Outstanding	6.067M shares	5.641M shares	5.666M shares
Diluted Shares Outstanding	6.067M shares		5.666M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.370M	$2.930M	$2.930M
YoY Change	104.55%	383.7%	383.7%
Cash & Equivalents	$1.370M	$2.926M	$2.930M
Short-Term Investments
Other Short-Term Assets	$361.8K	$250.0K	$250.0K
YoY Change	90.42%	17.12%	17.12%
Inventory	$2.971M	$2.776M	$2.780M
Prepaid Expenses	$361.8K	$249.7K
Receivables	$4.533M	$3.907M	$3.910M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.237M	$9.859M	$9.860M
YoY Change	31.36%	51.56%	51.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$412.7K	$433.5K	$790.0K
YoY Change	-30.17%	-30.91%	-31.02%
Goodwill	$8.824M	$8.824M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$9.832M	$9.881M	$9.880M
YoY Change	-3.01%	-3.11%	-3.13%
TOTAL ASSETS
Total Short-Term Assets	$9.237M	$9.859M	$9.860M
Total Long-Term Assets	$9.832M	$9.881M	$9.880M
Total Assets	$19.07M	$19.74M	$19.74M
YoY Change	11.07%	18.18%	18.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.734M	$2.432M	$2.430M
YoY Change	-24.82%	8.62%	8.52%
Accrued Expenses	$1.411M	$1.100M	$1.100M
YoY Change	10.22%	26.83%	26.83%
Deferred Revenue	$1.425M	$1.175M
YoY Change	37.96%	29.78%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$513.3K	$513.3K	$560.0K
YoY Change	38.18%	39.58%	37.11%
Total Short-Term Liabilities	$5.127M	$5.260M	$5.260M
YoY Change	-1.34%	14.67%	14.68%
LONG-TERM LIABILITIES
Long-Term Debt	$2.048M	$2.176M	$2.240M
YoY Change	9.77%	10.95%	8.06%
Other Long-Term Liabilities	$146.0K	$190.0K	$190.0K
YoY Change	-85.82%	-82.29%	-82.29%
Total Long-Term Liabilities	$2.048M	$2.176M	$2.430M
YoY Change	9.77%	10.95%	-22.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.127M	$5.260M	$5.260M
Total Long-Term Liabilities	$2.048M	$2.176M	$2.430M
Total Liabilities	$7.174M	$7.436M	$7.690M
YoY Change	1.6%	13.56%	-0.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.70M	-$48.24M
YoY Change	1.11%	0.3%
Common Stock	$60.67K	$60.67K
YoY Change	-64.14%	-64.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.69M	$12.05M	$12.05M
YoY Change
Total Liabilities & Shareholders Equity	$19.07M	$19.74M	$19.74M
YoY Change	11.07%	18.18%	18.18%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$464.4K	-$100.0K	-$144.6K
YoY Change	531.76%	-137.13%	-84.42%
Depreciation, Depletion And Amortization	$51.56K	$50.00K	$210.7K
YoY Change	-1.62%	-4.49%	10.78%
Cash From Operating Activities	-$1.373M	-$610.0K	-$81.09K
YoY Change	-787.41%	1042.32%	-91.31%
INVESTING ACTIVITIES
Capital Expenditures	$30.77K	$0.00	$16.78K
YoY Change	92.08%	-100.0%	-85.17%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$43.52K	$0.00	-$52.50K
YoY Change	49.16%	-100.0%	-87.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$128.3K		$367.3K
YoY Change	38.19%		48.72%
Cash From Financing Activities	-$138.9K	2.920M	$2.454M
YoY Change	35.08%	-1185.42%	126.09%
NET CHANGE
Cash From Operating Activities	-$1.373M	-610.0K	-$81.09K
Cash From Investing Activities	-$43.52K	0.000	-$52.50K
Cash From Financing Activities	-$138.9K	2.920M	$2.454M
Net Change In Cash	-$1.555M	2.310M	$2.320M
YoY Change	-2395.67%	-1122.89%	-1006.64%
FREE CASH FLOW
Cash From Operating Activities	-$1.373M	-$610.0K	-$81.09K
Capital Expenditures	$30.77K	$0.00	$16.78K
Free Cash Flow	-$1.404M	-$610.0K	-$97.87K
YoY Change	-864.1%	-3757.07%	-90.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000867840
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense		usd
CY2022	POCI	Effective Income Tax Rate Reconciliation Nol Utilization EffectiveIncomeTaxRateReconciliationNOLUtilization		pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-10647
CY2023	dei	Entity Registrant Name EntityRegistrantName	PRECISION OPTICS CORPORATION, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MA
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2795294
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	22 East Broadway
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Gardner
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01440
CY2023	dei	City Area Code CityAreaCode	(978)
CY2023	dei	Local Phone Number LocalPhoneNumber	630-1800
CY2023	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	POCI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	28343118	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6066518	shares
CY2023	dei	Auditor Firm AuditorFirmId	577
CY2023	dei	Auditor Name AuditorName	Stowe & Degon LLC
CY2023	dei	Auditor Location AuditorLocation	Westborough, Massachusetts
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2925852	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	605749	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	606715	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44135	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3907407	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2663872	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2776216	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	3022147	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	249681	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	213448	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	9859156	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	6505216	usd
CY2023Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3227481	usd
CY2022Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3215412	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	825752	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	843903	usd
CY2023Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	242865	usd
CY2022Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	219999	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4296098	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4279314	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3862578	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3651843	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	433520	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	627471	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	358437	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	517725	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	265111	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	229398	usd
CY2023Q2	us-gaap	Goodwill Goodwill	8824210	usd
CY2022Q2	us-gaap	Goodwill Goodwill	8824210	usd
CY2023Q2	us-gaap	Assets Assets	19740434	usd
CY2022Q2	us-gaap	Assets Assets	16704020	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	43209	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	40705	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	513259	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	367714	usd
CY2023Q2	POCI	Acquisition Earn Out Liability Current AcquisitionEarnOutLiabilityCurrent	0	usd
CY2022Q2	POCI	Acquisition Earn Out Liability Current AcquisitionEarnOutLiabilityCurrent	166667	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2432264	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2239175	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1174690	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	905113	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	927521	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	716702	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	168677	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	150565	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5259620	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4586641	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	68482	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	111691	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2175980	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1961141	usd
CY2023Q2	POCI	Acquisition Earn Out Liability Noncurrent AcquisitionEarnOutLiabilityNoncurrent	0	usd
CY2022Q2	POCI	Acquisition Earn Out Liability Noncurrent AcquisitionEarnOutLiabilityNoncurrent	705892	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	189760	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	367160	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6066518	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6066518	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5638302	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5638302	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	60665	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	56383	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60224934	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57009506	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48239007	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48094394	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12046592	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8971495	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19740434	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16704020	usd
CY2023	us-gaap	Revenues Revenues	21044467	usd
CY2022	us-gaap	Revenues Revenues	15678248	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	13310331	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	10750061	usd
CY2023	us-gaap	Gross Profit GrossProfit	7734136	usd
CY2022	us-gaap	Gross Profit GrossProfit	4928187	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	992375	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	666479	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7380309	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5613473	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	162125	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	8372684	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6442077	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-638548	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1513890	usd
CY2023	us-gaap	Interest Expense InterestExpense	218927	usd
CY2022	us-gaap	Interest Expense InterestExpense	155658	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	POCI	Gain On Revaluation Of Contingents Earnout Liabilities GainOnRevaluationOfContingentsEarnoutLiabilities	714798	usd
CY2022	POCI	Gain On Revaluation Of Contingents Earnout Liabilities GainOnRevaluationOfContingentsEarnoutLiabilities	742084	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-142677	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-927464	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1936	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	952	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144613	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-928416	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5666034	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5666034	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5295720	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5295720	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	3431127	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1490000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4000000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	63290	usd
CY2022	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	109682	shares
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	20000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	895494	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-928416	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8971495	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2288282	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12396	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	919032	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144613	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12046592	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-144613	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-928416	usd
CY2023	POCI	Gain On Revaluation Of Contingent Earnout Liabilities GainOnRevaluationOfContingentEarnoutLiabilities	705892	usd
CY2022	POCI	Gain On Revaluation Of Contingent Earnout Liabilities GainOnRevaluationOfContingentEarnoutLiabilities	742084	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	210735	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	190221	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	919032	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	915494	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4087	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	55017	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1243535	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	108140	usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-0	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-84210	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-245931	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	680744	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	36233	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-19312	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	193089	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	819284	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	269577	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-371650	usd
CY2023	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	206732	usd
CY2022	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-185875	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-81090	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-933371	usd
CY2023	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	-0	usd
CY2022	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	255062	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	35713	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	39543	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16784	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	113197	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52497	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-407802	usd
CY2023	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	40705	usd
CY2022	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	38349	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	367341	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	247002	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	750000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	22275	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	26000	usd
CY2023	POCI	Payment Of Acquisition Earnout Liability PaymentOfAcquisitionEarnoutLiability	166667	usd
CY2022	POCI	Payment Of Acquisition Earnout Liability PaymentOfAcquisitionEarnoutLiability	166667	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2288281	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1500000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12397	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	63290	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2453690	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1085272	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2320103	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-255901	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	605749	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	861650	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2925852	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	605749	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1936	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	912	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	20000	usd
CY2023	POCI	Acquisition Of Business Financed With Longterm Debt AcquisitionOfBusinessFinancedWithLongtermDebt	0	usd
CY2022	POCI	Acquisition Of Business Financed With Longterm Debt AcquisitionOfBusinessFinancedWithLongtermDebt	2600000	usd
CY2023	POCI	Common Stock Issued In Business Acquisition CommonStockIssuedInBusinessAcquisition	0	usd
CY2022	POCI	Common Stock Issued In Business Acquisition CommonStockIssuedInBusinessAcquisition	4000000	usd
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	reverse stock split on a one-for-three
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16915089	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5638302	shares
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	460460	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1310862	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1146691	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2776216	usd
CY2023	us-gaap	Revenues Revenues	21044467	usd
CY2022	us-gaap	Revenues Revenues	15678248	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	905113	usd
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	450084	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2545317	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3780215	usd
CY2023	POCI	Revenue Recognized RevenueRecognized	-2275740	usd
CY2022	POCI	Revenue Recognized RevenueRecognized	-3325186	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1174690	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	905113	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2925852	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	605749	usd
CY2023Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1142816	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1414996	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	322538	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	3022147	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	210735	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	245238	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zOVjDMGbBBtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(g)</b></span></td> <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zkEcxyJdNJVf">Significant Customers and Concentration of Credit Risk</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that subject the Company to credit risk consist primarily of cash equivalents and trade accounts receivable. The Company places its investments with highly rated financial institutions. The Company has not experienced any losses on these investments to date. At June 30, 2023 and 2022, two individual customer accounted for more <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230630__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zieARCPcTG8a" title="Concentration risk percentage"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJgtmxq9tDy6" title="Concentration risk percentage">10</span></span>% of the Company’s total accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The allowance for doubtful accounts receivable was $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_c20230630_zlqhFn7fwbfj" title="Allowance for doubtful accounts receivable">606,715</span> at June 30, 2023, and $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_c20220630_zOm7H9m593Sf" title="Allowance for doubtful accounts receivable">44,135</span> at June 30, 2022. In 2023, the Company increased the allowance for doubtful accounts to cover potential losses due to the insolvency of one customer. The Company generally does not require collateral or other security as a condition of sale, rather it relies on credit approval, balance limitation and monitoring procedures to control credit risk in trade account financial instruments. Management believes the allowance for doubtful accounts, which is established based upon review of specific account balances and historical experience, is adequate at June 30, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	606715	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44135	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-144613	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-928416	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5666034	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5666034	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5295720	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5295720	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1017041	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	904666	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	919032	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	895494	usd
CY2023Q2	POCI	Net Book Value Of Fixed Assets Under Capital Lease Obligations NetBookValueOfFixedAssetsUnderCapitalLeaseObligations	104208	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	358437	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	168677	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	189760	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_z7ull0IoraAk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(p)</b></span></td> <td style="width: 95%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zQsKM2Yhgpkd">Use of Estimates</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting standards generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	17122585	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-871121	usd
CY2022	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-0.16
CY2022	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.16
CY2019Q3	POCI	Earnout Contingent EarnoutContingent	500000	usd
CY2023Q2	POCI	Acquisition Earn Out Obligations Paid AcquisitionEarnOutObligationsPaid	500000	usd
CY2023Q2	POCI	Earn Out Liabilities EarnOutLiabilities	1500000	usd
CY2023Q2	us-gaap	Termination Loans TerminationLoans	1980952	usd
CY2023Q2	us-gaap	Loans Payable LoansPayable	750000	usd
CY2023Q2	POCI	Current Maturities CurrentMaturities	513259	usd
CY2023Q2	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	6190	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	41713	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2175980	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	513259	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	513259	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	513259	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	513259	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	513259	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	164657	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	2730952	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	919032	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	895494	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y3M18D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.019	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.77
CY2021Q4	us-gaap	Share Based Compensation ShareBasedCompensation	20000	usd
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	312500	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	833333	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	420000	shares
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1936	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	952	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.058	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.071	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.233	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.226	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	1.760	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.269	pure
CY2023	POCI	Effective Income Tax Rate Reconciliation Nol Utilization EffectiveIncomeTaxRateReconciliationNOLUtilization	0.050	pure
CY2023	POCI	Revaluation Of Contingent Earn Out Liability RevaluationOfContingentEarnOutLiability	-1.352	pure
CY2022	POCI	Revaluation Of Contingent Earn Out Liability RevaluationOfContingentEarnOutLiability	-0.218	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.056	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.003	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.013	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001	pure
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2617000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2640000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	247000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	164000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	407000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	512000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3271000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3316000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3271000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3316000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd

Files In Submission

Name	View Source	Status
poci-20230630_cal.xml	Edgar Link	unprocessable
0001683168-23-006801-index-headers.html	Edgar Link	pending
0001683168-23-006801-index.html	Edgar Link	pending
0001683168-23-006801.txt	Edgar Link	pending
0001683168-23-006801-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
poci-20230630.xsd	Edgar Link	pending
poci-20230630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
poci_ex0301.htm	Edgar Link	pending
poci_ex2301.htm	Edgar Link	pending
poci_ex3101.htm	Edgar Link	pending
poci_ex3102.htm	Edgar Link	pending
poci_ex3201.htm	Edgar Link	pending
poci_i10k-063023.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
poci-20230630_pre.xml	Edgar Link	unprocessable
poci-20230630_lab.xml	Edgar Link	unprocessable
poci_i10k-063023_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POCI
PRECISION OPTICS CORPORATION, INC. Stock $poci

2023 Q3 Form 10-K Financial Statement

#000168316823006801 Filed on September 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POCI PRECISION OPTICS CORPORATION, INC. Stock $poci

2023 Q3 Form 10-K Financial Statement

#000168316823006801 Filed on September 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POCI
PRECISION OPTICS CORPORATION, INC. Stock $poci